HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Control of tumor-associated macrophage alternative activation by macrophage migration inhibitory factor.

Abstract
Tumor stromal alternatively activated macrophages are important determinants of antitumor T lymphocyte responses, intratumoral neovascularization, and metastatic dissemination. Our recent efforts to investigate the mechanism of macrophage migration inhibitory factor (MIF) in antagonizing antimelanoma immune responses reveal that macrophage-derived MIF participates in macrophage alternative activation in melanoma-bearing mice. Both peripheral and tumor-associated macrophages (TAMs) isolated from melanoma bearing MIF-deficient mice display elevated proinflammatory cytokine expression and reduced anti-inflammatory, immunosuppressive, and proangiogenic gene products compared with macrophages from tumor-bearing MIF wild-type mice. Moreover, TAMs and myeloid-derived suppressor cells from MIF-deficient mice exhibit reduced T lymphocyte immunosuppressive activities compared with those from their wild-type littermates. Corresponding with reduced tumor immunosuppression and neo-angiogenic potential by TAMs, MIF deficiency confers protection against transplantable s.c. melanoma outgrowth and melanoma lung metastatic colonization. Finally, we report for the first time, to our knowledge, that our previously discovered MIF small molecule antagonist, 4-iodo-6-phenylpyrimidine, recapitulates MIF deficiency in vitro and in vivo, and attenuates tumor-polarized macrophage alternative activation, immunosuppression, neoangiogenesis, and melanoma tumor outgrowth. These studies describe an important functional contribution by MIF to TAM alternative activation and provide justification for immunotherapeutic targeting of MIF in melanoma patients.
AuthorsKavitha Yaddanapudi, Kalyani Putty, Beatriz E Rendon, Gwyneth J Lamont, Jonathan D Faughn, Abhay Satoskar, Amanda Lasnik, John W Eaton, Robert A Mitchell
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 190 Issue 6 Pg. 2984-93 (Mar 15 2013) ISSN: 1550-6606 [Electronic] United States
PMID23390297 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Macrophage Migration-Inhibitory Factors
Topics
  • Animals
  • Carcinoma, Lewis Lung (immunology, metabolism, pathology)
  • Cell Line, Tumor
  • Cells, Cultured
  • Lung Neoplasms (immunology, metabolism, pathology)
  • Macrophage Activation (genetics, immunology)
  • Macrophage Migration-Inhibitory Factors (biosynthesis, deficiency, physiology)
  • Macrophages, Peritoneal (immunology, metabolism, pathology)
  • Male
  • Melanoma, Experimental (immunology, metabolism, pathology)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Transgenic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: